Drug monitoring at an Australia depot phenothiazine clinic.
Three aspects of treatment with injectable neuroleptics, are presented. An individualized approach to the dosage of Fluphenazine decanoate must be practiced in conjunction with, and taking into account the time spent in treatment and the sex and age variables reported. Our flexible approach to the interval between injections, indicated a large group could be maintained at intervals of 5 to 8 weeks. Complex and challenging problems can be found with antiparkinsonian drugs; 30% of nearly 400 outpatients still require these drugs.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage; D001315:Australia; D002908:Chronic Disease; D003651:Decanoates; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000517:prevention & control; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D010044:Outpatient Clinics, Hospital; D012559:Schizophrenia / Q000188:drug therapy; D012737:Sex Factors
D000978:Antiparkinson Agents; D003651:Decanoates; D003692:Delayed-Action Preparations; D005476:Fluphenazine